Ben Sluckis
Clalit Health Services(IL)
Publications by Year
Research Areas
Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Pharmacology and Obesity Treatment, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis(2022)40 cited
- → Liraglutide versus semaglutide for weight reduction—a cost needed to treat analysis(2023)23 cited
- → Author response for "Tirzepatide vs. Semaglutide for Weight Loss In Patients With Type 2 Diabetes Mellitus ‐ A Value For Money Analysis"(2022)1 cited
- → Abstract 15300: Tirzepatide vs. Semaglutide for Weight Loss in Patients With Type 2 Diabetes Mellitus - A Value for Money Analysis(2022)1 cited
- → Abstract 13465: Tirzepatide vs. Semaglutide for Secondary Prevention of Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus With an Initial HbA1c of >8.5 - A Value for Money Analysis(2023)
- → Abstract 13050: Tirzepatide versus Semaglutide for Secondary Prevention of Major Adverse Cardiovascular Events in Patients Over the Age of 65 With Type 2 Diabetes Mellitus-Value per Money Analysis(2022)